Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCarclo Regulatory News (CAR)

Share Price Information for Carclo (CAR)

Share Price is delayed by 15 minutes
Get Live Data
36.00    -0.70 (-1.91%)
Bid:
36.00
Ask:
37.40
Spread: 1.40 (3.889%)
Market Cap: £26.43m
CAR Live PriceLast checked at - London Stock Exchange

Intraday Carclo Share Chart

Interim Management Statement

12 Aug 2011 07:00

RNS Number : 2413M
Carclo plc
12 August 2011
 



12 August 2011

 

Carclo plc

("Carclo" or "the Group")

 

Interim Management Statement

 

Trading continues to be in line with our expectations and we remain confident of a further year of progress for the group as a whole.

 

Technical Plastics continues to benefit from growth in its medical diagnostic business and our newly established Indian operation has seen especially strong demand. Last year's first half profit in Technical Plastics was unusually strong due to the timing of tooling contracts. In the current year the division will revert to the normal profit pattern with stronger second half profits.

 

In Precision Products, specialist LED lighting sales at Wipac continue to grow and, as announced with our preliminary results, we have been awarded two new substantial supercar programmes. We are involved in a number of other interesting new projects which, if confirmed, will add further growth in this business. Our withdrawal from the supply of automotive antennas and cables to Ford is proceeding to plan and will be essentially complete by the end of this financial year. The aerospace businesses continue to perform well.

 

Conductive Inkjet Technology ("CIT") completed the validation of the Gen 3 technology for fine line touch screens as planned at the end of June. The migration from Gen 2 to Gen 3 was more challenging than we anticipated and it is to the credit of the team at CIT that validation was achieved on time. Our next target is to be fully production ready by the end of September - recent progress is encouraging and we are confident of meeting this next milestone. We continue to expect volume production to commence in our fourth quarter.

 

The Group's financial position remains strong. In our preliminary results announcement we stated that discussions had commenced with our banks in order to achieve an early renewal of the Group's committed bank facilities. Good progress has been made in these discussions and we now expect to complete our re-financing ahead of schedule during the next few months.

 

- ENDS -

 

Enquiries:

 

 

 

Carclo plc

01924 268040

Ian Williamson, Chief Executive

 

Robert Brooksbank, Finance Director

 

 

 

Weber Shandwick Financial

020 7067 0700

Nick Oborne / Stephanie Badjonat / Robert Cook

 

 

Notes to editors

 

·; Carclo plc is a technology led plastics group. It is a public company whose shares are quoted on the London Stock Exchange.

 

·; Two thirds of sales are derived from the supply of fine tolerance, injection moulded plastic components, which are used in medical, optical and electronics products. This business, Carclo Technical Plastics, operates internationally in a fast growing and dynamic market underpinned by rapid technological development.

 

·; A third of sales are derived from the supply of specialised precision products to the premium automotive and aerospace industries. Carclo is a leader in the development of high power LED lighting for supercars.

 

·; Carclo's strategy is to develop new technologies and products to drive future growth. Its investment in Conductive Inkjet Technology is at the heart of the newly emerging market for very low cost printed electronics.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSGGUMGRUPGGQG
Date   Source Headline
27th Apr 20217:00 amRNSFull Year Trading Update
22nd Apr 20219:13 amRNSHolding(s) in Company
25th Feb 202110:32 amRNSHolding(s) in Company
24th Feb 202110:31 amRNSHolding(s) in Company
22nd Feb 202110:28 amRNSHolding(s) in Company
18th Feb 202111:19 amRNSHolding(s) in Company
12th Feb 20217:00 amRNSAppointment of Director and CFO
5th Feb 20217:00 amRNSDirector/PDMR Shareholding
4th Feb 20214:35 pmRNSPrice Monitoring Extension
4th Feb 20214:15 pmRNSDirector/PDMR Shareholding
3rd Feb 20214:41 pmRNSSecond Price Monitoring Extn
3rd Feb 20214:35 pmRNSPrice Monitoring Extension
22nd Jan 20217:00 amRNSDirector Appointment
8th Jan 20217:00 amRNSDirector Appointment
7th Jan 202111:35 amRNSDirector/PDMR Shareholding
5th Jan 20214:40 pmRNSDirector/PDMR Shareholding
23rd Dec 20207:00 amRNSFramework Agreement
15th Dec 202010:07 amRNSAppointment of Interim CFO
27th Nov 20207:01 amRNSBoard Changes
27th Nov 20207:00 amRNSHalf Year Results
26th Nov 20204:41 pmRNSSecond Price Monitoring Extn
26th Nov 20204:35 pmRNSPrice Monitoring Extension
12th Nov 20204:33 pmRNSNotice of Interim Results
10th Nov 20204:41 pmRNSSecond Price Monitoring Extn
10th Nov 20204:36 pmRNSPrice Monitoring Extension
5th Oct 20207:00 amRNSBoard restructure
2nd Oct 20204:41 pmRNSSecond Price Monitoring Extn
2nd Oct 20204:36 pmRNSPrice Monitoring Extension
30th Sep 20207:00 amRNSAppointment of Non-Executive Chairman
29th Sep 202012:18 pmRNSResult of AGM
4th Sep 202011:04 amRNS2020 Annual Report & Accounts & Notice of 2020 AGM
25th Aug 20204:46 pmRNSDirector/PDMR Shareholding
25th Aug 20207:00 amRNSPreliminary Results for the year ended 31 March 20
18th Aug 20207:00 amRNSAppointment of NED and Chairman-elect
17th Aug 20207:00 amRNSUpdate on refinancing and current trading
4th May 20204:41 pmRNSSecond Price Monitoring Extn
4th May 20204:35 pmRNSPrice Monitoring Extension
4th May 20207:00 amRNSFull Year Trading Statement and COVID-19 Update
1st May 20204:24 pmRNSHolding(s) in Company
28th Apr 20204:41 pmRNSSecond Price Monitoring Extn
28th Apr 20204:37 pmRNSPrice Monitoring Extension
27th Apr 20207:00 amRNSAppointment of Chairman
14th Apr 20202:41 pmRNSExternal Auditor Appointment
8th Apr 20202:39 pmRNSHolding(s) in Company
8th Apr 20209:03 amRNSHolding(s) in Company
6th Apr 20201:35 pmRNSHolding(s) in Company
3rd Apr 202011:40 amRNSHolding(s) in Company
30th Mar 20204:40 pmRNSSecond Price Monitoring Extn
30th Mar 20204:36 pmRNSPrice Monitoring Extension
24th Mar 20207:00 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.